Birth* | Variables | OR | 95% CI |
---|---|---|---|
Female twins | Dosage of Gn (× 103 IU/L) | 0.931 | 0.805–1.076 |
 | Days of Gn use (day) | 1.021 | 0.977–1.067 |
 | Age difference |  |  |
 |  Older mother | 0.815 | 0.546–1.215 |
 |  Older father | 0.864 | 0.629–1.187 |
 |   None | 1.000 |  |
 | Embryo transfer stage |  |  |
 |  Cleavage stage | 0.783 | 0.530–1.158 |
 |  Blastocyst | 1.000 |  |
 | Paternal age group (year) |  |  |
 |  ≤30 | 1.056 | 0.773–1.444 |
 |  31–32 | 0.988 | 0.712–1.371 |
 |  33–35 | 1.072 | 0.794–1.448 |
 |  ≥36 | 1.000 |  |
 | Maternal BMI |  |  |
 |  <18.5 | 1.129 | 0.770–1.654 |
 |  18.5–23.9 | 1.048 | 0.786–1.396 |
 |  ≥24 | 1.000 |  |
 | Fertilization method |  |  |
 |  IVF | 1.061 | 0.703–1.600 |
 |  ICSI | 0.844 | 0.514–1.386 |
 |  FET | 1.000 |  |
Boy-girl twins | Dosage of Gn (× 103 IU/L) | 0.837 | 0.715–0.980 |
 | Days of Gn use (day) | 1.032 | 0.985–1.081 |
 | Age difference |  |  |
 |  Older mother | 0.917 | 0.616–1.366 |
 |  Older father | 0.682 | 0.492–0.945 |
 |  None | 1.000 |  |
 | Embryo transfer stage |  |  |
 |  Cleavage stage | 1.754 | 1.133–2.716 |
 |  Blastocyst | 1.000 |  |
 | Paternal age group (year) |  |  |
 |  ≤30 | 0.939 | 0.672–1.312 |
 |  31–32 | 0.972 | 0.686–1.377 |
 |  33–35 | 0.995 | 0.719–1.377 |
 |  ≥36 | 1.000 |  |
 | Maternal BMI |  |  |
 |  <18.5 | 1.340 | 0.892–2.012 |
 |  18.5–23.9 | 1.160 | 0.845–1.591 |
 |  ≥24 | 1.000 |  |
 | Fertilization method |  |  |
 |  IVF | 0.846 | 0.546–1.312 |
 |  ICSI | 0.882 | 0.531–1.464 |
 |  FET | 1.000 |  |